Anaplastic lymphoma kinase (alk) as oncoantigen for lymphoma...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/00 (2006.01) A61K 38/45 (2006.01) A61P 35/00 (2006.01) A61K 31/7088 (2006.01)

Patent

CA 2640655

Use of intracytoplasmatic domain of Anaplastic Lymphoma Kinase (ALK) protein and/or a nucleic acid molecule encoding for the intracytoplasmatic domain of Anaplastic Lymphoma Kinase (ALK) protein, of any species, for the preparation of a medicament, preferably a vaccine, for the treatment and/or prevention of a tumor in a subject, preferably a lymphoma.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Anaplastic lymphoma kinase (alk) as oncoantigen for lymphoma... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anaplastic lymphoma kinase (alk) as oncoantigen for lymphoma..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anaplastic lymphoma kinase (alk) as oncoantigen for lymphoma... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1459233

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.